This product is free for DNS members.
This webinar was presented live on June 30, 2020.
IV Lipid Emulsions are in a state of constant evolution. Staying up-to-date with these changes and understanding the benefits and limitations of these products, along with understanding how to add these products to the formulary at an institution is vital to the success of clinicians and patients. The final part of a four-part series will provide the unique perspective of a pharmacist, poised to share essential knowledge with clinicians.
Financial support for this webinar series is provided by Baxter.
CPE Level: 2
Performance Indicators: 10.4.2, 14.3.3, 4.1.1
- Describe the characteristics of commercially available Intravenous Lipid Emulsions (ILEs) in the US
- Contrast the benefits and limitations of available ILE
- Review the process for adding an intravenous (IV) nutritional product to an institutional formulary
- Design an effective communication strategy for evaluating ILEs for formulary consideration
Leslie N. Schechter, RPh, B.S., Pharm.D.
Advanced Practice Pharmacist, Pain Management and Nutritional Support
Thomas Jefferson University Hospital, Philadelphia, PA